Human umbilical cord blood-derived stromal cell, a new resource of feeder layer to expand human umbilical cord blood CD34 + cells in vitro

• Published in: Blood cells, molecules, & diseases Vol. 36; no. 2; pp. 322 - 328
• Main Authors: Gao, Lei, Chen, Xinghua, Zhang, Xi, Liu, Yao, Kong, Peiyan, Peng, Xiangui, Liu, Lin, Liu, Hong, Zeng, Dongfeng
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.03.2006
• Subjects: Antigens, CD34; CD34 + cell; Cell Culture Techniques; Cell Proliferation; Coculture Techniques; Cytokines - pharmacology; Dexter cultures; Fetal Blood; Hematopoietic Stem Cells - cytology; Humans; Immunophenotyping; In vitro expansion; Stromal cells; Stromal Cells - cytology; Umbilical cord blood; CD34 + cell; CFU-Mg; Umbilical cord blood; DMSO; EPO; GVHD; HS; FITC; TPO; GM-CSF; MNCs; RT-PCR; CFU-GM; HSC; CFU-E; HSCT; PBS; Ln; MACS; Fn; IL-3; HIM; bFGF; In vitro expansion; Stromal cells; FCS; SCF; NOD/SCID; PI; Dexter cultures; hUCB; ELISA
• ISSN: 1079-9796; 1096-0961
• DOI: 10.1016/j.bcmd.2005.12.036

Allogeneic transplantation with human umbilical cord blood (hUCB) in adult recipients is mainly limited by a low CD34 + cell dose. To break the limit, hUCB as a novel source of hUCB-derived stromal cells was incorporated in an attempt to expand CD34 + cells from hUCB in vitro. Cord blood CD34 + cells were separated by MACS system. HUCB-derived stromal cells were cultured by the Dexter system and characterized by morphologic, immunophenotypical, and functional analysis. We studied the effects of hUCB-derived stromal cells, cytokines, and hUCB-derived stromal cells combined with cytokines on expansion of hUCB CD34 + cells. The CD34 + cells were assessed for the degree of expansion and the number of colony-forming units in semisolid culture. Our research found that hUCB-derived stromal cells were mainly composed of three kinds of cell components, with CD106, CD29, CD44, CD45, CD50, CD68, CD31, Fn, Lm, and collagen IV positive, but CD34 negative immunophenotype. Functionally, it was discovered by cell cycle and growth curve analyses that the capability of colony and parietal layer formation of hUCB-derived stromal cells was poorer than that of BM stromal cells, and the doubling time of hUCB-derived stromal cells was longer than that of BM stromal cells. It was indicated by ELISA and RT-PCR that hUCB-derived stromal cells express higher level of TPO and less GM-CSF and SCF than BM stromal cell. Adherent layer of hUCB-derived stromal cells alone or combining with cytokines, increased CD34 + cell expansion. In vitro formation of CFUs by expanded CD34 + cells was significantly higher than that of unexpanded CD34 + cells ( P < 0.05). When cocultured with hUCB-derived stromal cells in the presence of cytokines, cell growth was significantly enhanced: CD34 + cells by 8.02 ± 0.96-fold, CFU-GM by 217.60 ± 6.72-fold, CFU-E by 1940.80 ± 52.78-fold, and CFU-Mg by 142.60 ± 4.39-fold. HUCB-derived stromal cells have significant superiority on the expansion of CFU-Mg ( P < 0.05). The results indicate that human umbilical cord blood-derived stromal cells may be a suitable feeder layer for expansion of hematopoietic progenitors from hUCB in vitro.